Mohammad Amjad Kamal

22.4k total citations · 5 hit papers
598 papers, 15.5k citations indexed

About

Mohammad Amjad Kamal is a scholar working on Molecular Biology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Mohammad Amjad Kamal has authored 598 papers receiving a total of 15.5k indexed citations (citations by other indexed papers that have themselves been cited), including 201 papers in Molecular Biology, 123 papers in Pharmacology and 97 papers in Computational Theory and Mathematics. Recurrent topics in Mohammad Amjad Kamal's work include Computational Drug Discovery Methods (97 papers), Cholinesterase and Neurodegenerative Diseases (93 papers) and Alzheimer's disease research and treatments (58 papers). Mohammad Amjad Kamal is often cited by papers focused on Computational Drug Discovery Methods (97 papers), Cholinesterase and Neurodegenerative Diseases (93 papers) and Alzheimer's disease research and treatments (58 papers). Mohammad Amjad Kamal collaborates with scholars based in Saudi Arabia, India and China. Mohammad Amjad Kamal's co-authors include Nigel H. Greig, Shazi Shakil, Gohar Mushtaq, Shams Tabrez, Ghulam Md Ashraf, Nasimudeen R. Jabir, Syed Mohd Danish Rizvi, Sibhghatulla Shaikh, Siew Hua Gan and Haroon Khan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Mohammad Amjad Kamal

579 papers receiving 15.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment

2014 554 citations Mohammad Amjad Kamal et al. profile →
Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy

2019 324 citations Mohammad Amjad Kamal et al. profile →
Essential Oils: Extraction Techniques, Pharmaceutical And Therapeutic Potential - A Review

2018 313 citations Mohammad Amjad Kamal et al. Current Drug Metabolism profile →
Flavonoids as acetylcholinesterase inhibitors: Current therapeutic standing and future prospects

2018 238 citations Mohammad Amjad Kamal et al. profile →
Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic

2022 188 citations Mohammad Amjad Kamal et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mohammad Amjad Kamal Saudi Arabia	58	5.3k	2.3k	2.0k	1.3k	1.3k	598	15.5k
Md. Imtaiyaz Hassan India	63	8.8k 1.7×	1.5k 0.7×	1.7k 0.8×	2.4k 1.8×	627 0.5×	648	16.8k
Haroon Khan Pakistan	65	6.2k 1.2×	1.8k 0.8×	1.0k 0.5×	608 0.5×	619 0.5×	566	16.2k
Subash C. Gupta India	55	8.6k 1.6×	1.7k 0.7×	1.5k 0.7×	335 0.3×	796 0.6×	123	19.0k
Ghulam Md Ashraf Saudi Arabia	56	3.4k 0.6×	1.3k 0.6×	2.4k 1.2×	697 0.5×	630 0.5×	353	10.5k
Talha Bin Emran Bangladesh	64	4.5k 0.9×	1.4k 0.6×	590 0.3×	1.1k 0.8×	1.0k 0.8×	531	17.0k
Aiping Lü China	68	10.6k 2.0×	1.8k 0.8×	775 0.4×	2.8k 2.1×	1.5k 1.2×	549	20.7k
Solomon Habtemariam United Kingdom	54	4.7k 0.9×	1.8k 0.8×	700 0.4×	388 0.3×	1.6k 1.2×	244	13.5k
Kamal Dua Australia	59	5.3k 1.0×	1.1k 0.5×	1.2k 0.6×	290 0.2×	1.8k 1.4×	627	16.0k
Qi Wang China	55	6.7k 1.3×	1.3k 0.6×	2.4k 1.2×	715 0.5×	631 0.5×	742	15.4k
Seyed Mohammad Nabavi Iran	71	6.1k 1.2×	1.8k 0.8×	1.4k 0.7×	403 0.3×	501 0.4×	274	16.5k

Countries citing papers authored by Mohammad Amjad Kamal

Since Specialization

Citations

This map shows the geographic impact of Mohammad Amjad Kamal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Amjad Kamal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Amjad Kamal more than expected).

Fields of papers citing papers by Mohammad Amjad Kamal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Amjad Kamal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Amjad Kamal. The network helps show where Mohammad Amjad Kamal may publish in the future.

Co-authorship network of co-authors of Mohammad Amjad Kamal

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Amjad Kamal. A scholar is included among the top collaborators of Mohammad Amjad Kamal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Amjad Kamal. Mohammad Amjad Kamal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pandit, Anand, Danyal Z. Khan, Georg H. Reischer, et al.. (2025). Mapping Pituitary Neuroendocrine Tumors: An Annotated MRI Dataset Profiling Tumor and Carotid Characteristics. Scientific Data. 12(1). 80–80. 2 indexed citations

Kamal, Mohammad Amjad, et al.. (2025). A Comprehensive Mini-Review on the Understanding of Electrotherapyfor Pain Management: An Introduction to ABMMA-BMT. Current Pharmaceutical Biotechnology. 26.

Αλεξίου, Αθανάσιος, et al.. (2024). The use of Isoflavones as Lung Cancer Chemoprevention Agents and their Implications in Treatment through Radio Sensitization. Current Medicinal Chemistry. 32(2). 214–237.

Akhtar, Salman, et al.. (2024). Diabetes Mellitus: Exploring Biomarkers, Complications, and Therapeutic Strategies with a Spotlight on Cyanobacterial Bioactive Compounds - A Comprehensive Review. Current Diabetes Reviews. 21(10). 31–49.

Beniwal, Meenu, et al.. (2024). Role and Responsibilities of Various Stakeholders in Pharmacovigilance. Current Drug Safety. 20(1). 19–32. 5 indexed citations

Bhandari, Divya Dhawal, et al.. (2024). Neuroprotective Potential of Heterocyclic Scaffolds vs Herbal Treatments: An Overview. Research Journal of Pharmacy and Technology. 2943–2948.

Singla, Rajeev K., et al.. (2023). Current trends in natural products for the treatment and management of dementia: Computational to clinical studies. Neuroscience & Biobehavioral Reviews. 147. 105106–105106. 6 indexed citations

Verras, Georgios‐Ioannis, et al.. (2022). The Association Between the Risk of Breast Cancer and Epigallocatechin-3-Gallate Intake: A Literature Review of a Potential ChemopreventiveAgent. Current Medicinal Chemistry. 29(40). 6169–6196. 3 indexed citations

Khan, Andleeb, Saeed Alshahrani, Hina Rashid, et al.. (2021). Inflammation and Alzheimer’s Disease: Mechanisms and Therapeutic Implications by Natural Products. Mediators of Inflammation. 2021(1). 9982954–9982954. 65 indexed citations

10.

El‐Kafrawy, Sherif A., Mai M. El-Daly, Ahmed M. Hassan, et al.. (2021). A Direct Method for RT-PCR Detection of SARS-CoV-2 in Clinical Samples. Healthcare. 9(1). 37–37. 12 indexed citations

11.

Singh, Indrakant K., Pooja Mittal, Amit Kumar, et al.. (2021). Emerging Therapeutic Approaches to COVID-19. Current Pharmaceutical Design. 27(31). 3370–3388. 4 indexed citations

12.

Bharadwaj, Shiv, Sherif A. El‐Kafrawy, Thamir A. Alandijany, et al.. (2021). Structure-Based Identification of Natural Products as SARS-CoV-2 Mpro Antagonist from Echinacea angustifolia Using Computational Approaches. Viruses. 13(2). 305–305. 27 indexed citations

13.

Ahmad, Wasim, et al.. (2021). Functional Neuroproteomics: An Imperative Approach for Unravelling Protein Implicated Complexities of Brain. CNS & Neurological Disorders - Drug Targets. 20(7). 613–624. 3 indexed citations

14.

Kamal, Mohammad Amjad, et al.. (2020). Tubulin Proteins in Cancer Resistance: A Review. Current Drug Metabolism. 21(3). 178–185. 25 indexed citations

15.

Bibi, Shabana, Yuanbing Wang, Dexiang Tang, Mohammad Amjad Kamal, & Hong Yu. (2019). Prospects for Discovering the Secondary Metabolites of Cordyceps Sensu Lato by the Integrated Strategy. Medicinal Chemistry. 17(2). 97–120. 10 indexed citations

16.

Liu, Yang, et al.. (2019). Influence of Hormones on Sjögren’s Syndrome. Current Pharmaceutical Design. 24(35). 4167–4176. 7 indexed citations

17.

Adil, Muhammad, Fazal Adnan, Imran Khan, et al.. (2018). Association of Metronidazole with Cancer: A Potential Risk Factor or Inconsistent Deductions?. Current Drug Metabolism. 19(11). 902–909. 20 indexed citations

18.

Jabir, Nasimudeen R., et al.. (2017). An overview on the current status of cancer nanomedicines. Current Medical Research and Opinion. 34(5). 911–921. 40 indexed citations

19.

Jabir, Nasimudeen R., Chelapram K. Firoz, Farid Ahmed, et al.. (2017). Reduction in CD16/CD56 and CD16/CD3/CD56 Natural Killer Cells in Coronary Artery Disease. Immunological Investigations. 46(5). 526–535. 18 indexed citations

20.

Li, Zhiying, et al.. (2015). Observations on the expression of human papillomavirus major capsid protein in HeLa cells. Cancer Cell International. 15(1). 53–53. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact